803
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

Benralizumab for the treatment of asthma

, &
Pages 405-413 | Received 19 Dec 2016, Accepted 03 Apr 2017, Published online: 19 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Ahmed Yousuf & Christopher E Brightling. (2018) Biologic Drugs: A New Target Therapy in COPD?. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 99-107.
Read now
Daniel Colodenco, Oscar Palomares, Carlos Celis, Alan Kaplan & Christian Domingo. (2018) Moving toward consensus on diagnosis and management of severe asthma in adults. Current Medical Research and Opinion 34:3, pages 387-399.
Read now
Amelia Licari, Riccardo Castagnoli, Ilaria Brambilla, Alessia Marseglia, Maria Angela Tosca, Gian Luigi Marseglia & Giorgio Ciprandi. (2018) New approaches for identifying and testing potential new anti-asthma agents. Expert Opinion on Drug Discovery 13:1, pages 51-63.
Read now

Articles from other publishers (13)

Hanna K. Mandl, Jessa E. Miller & Daniel M. Beswick. (2023) Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps. Otolaryngologic Clinics of North America.
Crossref
Hsu-Hui Wang & Shih-Lung Cheng. (2021) From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease. Biomedicines 9:11, pages 1638.
Crossref
Donald J. AbrahamRobert M. Borzilleri, Amy C. Hart, Ryan Moslin, John S. Tokarski & Stephen T. Wrobleski. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 86 .
Manuel J. Rial, José A. Cañas, José M. Rodrigo-Muñoz, Marcela Valverde-Monge, Beatriz Sastre, Joaquín Sastre & Victoria del Pozo. (2021) Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma. International Journal of Molecular Sciences 22:7, pages 3558.
Crossref
Javier Checa & Josep M. Aran. (2020) Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. International Journal of Molecular Sciences 21:23, pages 9317.
Crossref
Wanling Liang, Harry W. Pan, Driton Vllasaliu & Jenny K. W. Lam. (2020) Pulmonary Delivery of Biological Drugs. Pharmaceutics 12:11, pages 1025.
Crossref
Grzegorz Kardas, Piotr Kuna & Michał Panek. (2020) Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling. Frontiers in Immunology 11.
Crossref
Koichi Ando, Akihiko Tanaka & Hironori Sagara. (2020) Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review. International Journal of Molecular Sciences 21:3, pages 889.
Crossref
Ton C. Doan, Brian M. Jeong, Mackenzie E. Coden, Lucas F. Loffredo, Swati Bhattacharyya, Sergio E. Chiarella, John Varga, Hiam Abdala-Valencia & Sergejs Berdnikovs. (2018) Matrix protein tenascin-C expands and reversibly blocks maturation of murine eosinophil progenitors. Journal of Allergy and Clinical Immunology 142:2, pages 695-698.e4.
Crossref
Ann Christin Reiersølmoen, Jin Han, Eirik Sundby & Bård Helge Hoff. (2018) Identification of fused pyrimidines as interleukin 17 secretion inhibitors. European Journal of Medicinal Chemistry 155, pages 562-578.
Crossref
Maciej Kupczyk & Piotr Kuna. (2018) Benralizumab: an anti-IL-5 receptor α monoclonal antibody in the treatment of asthma. Immunotherapy 10:5, pages 349-359.
Crossref
Tara Vinyette Saco, Amber Pepper & Thomas B. Casale. (2018) Uses of biologics in allergic diseases. Annals of Allergy, Asthma & Immunology 120:4, pages 357-366.
Crossref
Amber N. Pepper, Harald Renz, Thomas B. Casale & Holger Garn. (2017) Biologic Therapy and Novel Molecular Targets of Severe Asthma. The Journal of Allergy and Clinical Immunology: In Practice 5:4, pages 909-916.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.